PCSK9 monoclonal antibodies and lipoprotein apheresis for lowering lipoprotein(a): making choices in an era of RNA-based therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PCSK9 monoclonal antibodies and lipoprotein apheresis for lowering lipoprotein(a): making choices in an era of RNA-based therapies

Published:2019-03-07 Issue:9 Volume:26 Page:998-1000
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:Eur J Prev Cardiolog

Author:

Ruscica Massimiliano¹,Watts Gerald F²³⁴,Sirtori Cesare R⁵

Affiliation:

1. Department of Pharmacological and Bimolecular Sciences, Università degli Studi di Milano, Italy

2. School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Australia

3. Lipid Disorders Clinic, Royal Perth Hospital, Australia

4. Familial Hypercholesterolaemia Australia Network, Australia

5. Centro Dislipidemie, ASST Grande Ospedale Metropolitano Niguarda, Italy

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

http://journals.sagepub.com/doi/pdf/10.1177/2047487319833504

Reference23 articles.

1. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

2. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

3. Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else?

4. Application of PCSK9 Inhibitors in Practice

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal antibodies for dyslipidemia in adults: a focus on vulnerable patients groups;Expert Opinion on Biological Therapy;2024-02-23

2. Major cardiovascular events increase in long-term proprotein convertase subtilisin/kexin type 9 inhibitors therapy: the Tuscany cost-effective study;Journal of Cardiovascular Medicine;2023-09-29

3. Lipoprotein Apheresis for Reduction of Lipoprotein(a);Contemporary Cardiology;2023

4. A method for lipoprotein (a) Isolation from a small volume of plasma with applications for clinical research;Scientific Reports;2022-06-01

5. Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena);European Journal of Preventive Cardiology;2020-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3